Your browser doesn't support javascript.
loading
The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies.
Andersen, Johanna B; Sharmin, Sifat; Lefort, Mathilde; Koch-Henriksen, Nils; Sellebjerg, Finn; Sørensen, Per Soelberg; Hilt Christensen, Claudia C; Rasmussen, Peter V; Jensen, Michael B; Frederiksen, Jette L; Bramow, Stephan; Mathiesen, Henrik K; Schreiber, Karen I; Horakova, Dana; Havrdova, Eva K; Alroughani, Raed; Izquierdo, Guillermo; Eichau, Sara; Ozakbas, Serkan; Patti, Francesco; Onofrj, Marco; Lugaresi, Alessandra; Terzi, Murat; Grammond, Pierre; Grand Maison, Francois; Yamout, Bassem; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Boz, Cavit; Trojano, Maria; McCombe, Pamela; Slee, Mark; Lechner-Scott, Jeannette; Turkoglu, Recai; Sola, Patrizia; Ferraro, Diana; Granella, Franco; Shaygannejad, Vahid; Prevost, Julie; Skibina, Olga; Solaro, Claudio; Karabudak, Rana; Wijmeersch, Bart V; Csepany, Tunde; Spitaleri, Daniele; Vucic, Steve; Casey, Romain; Debouverie, Marc; Edan, Gilles.
Afiliación
  • Andersen JB; The Danish Multiple Sclerosis Registry, Department of Neurology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark. Electronic address: johanna.balslev.andersen@regionh.dk.
  • Sharmin S; CORe, Department of Medicine, University of Melbourne, Melbourne, Australia; Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
  • Lefort M; Rennes University, EHESP, REPERES - EA 7449, F-35000 Rennes, France; Univ Rennes, CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes), F-35000 Rennes, France.
  • Koch-Henriksen N; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
  • Sellebjerg F; The Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet Glostrup, Denmark.
  • Sørensen PS; The Danish Multiple Sclerosis Center, Department of Neurology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
  • Hilt Christensen CC; Department of Neurology Aalborg University Hospital, Multiple Sclerosis Unit.
  • Rasmussen PV; Aarhus University Hospital, Neurology, PPJ Boulevard, DK-8200 Aarhus N.
  • Jensen MB; Department of Neurology, University Hospital of Northern Sealand.
  • Frederiksen JL; Danish Multiple Sclerosis Centre, Dept. of Neurology, Copenhagen University Hospital, Rigshospitalet in Glostrup, 2600 Glostrup, Denmark.
  • Bramow S; The Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet Glostrup, Denmark.
  • Mathiesen HK; The Danish Multiple Sclerosis Center, Department of Neurology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
  • Schreiber KI; The Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet Glostrup, Denmark.
  • Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
  • Havrdova EK; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
  • Alroughani R; Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait.
  • Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Eichau S; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Ozakbas S; Dokuz Eylul University, Konak/Izmir, Turkey.
  • Patti F; GF Ingrassia Department, University of Catania, Catania, Policlinico G Rodolico, Italy.
  • Onofrj M; Department of Neuroscience, Imaging, and Clinical Sciences, University G. d'Annunzio, Chieti, Italy.
  • Lugaresi A; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Terzi M; Medical Faculty, 19 Mayis University, Samsun, Turkey.
  • Grammond P; CISSS Chaudiere-Appalache, Levis, Canada.
  • Grand Maison F; Neuro Rive-Sud, Quebec, Canada.
  • Yamout B; Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.
  • Prat A; Hopital Notre Dame, Montreal, Canada, CHUM and Universite de Montreal, Montreal, Canada.
  • Girard M; Hopital Notre Dame, Montreal, Canada, CHUM and Universite de Montreal, Montreal, Canada.
  • Duquette P; Hopital Notre Dame, Montreal, Canada, CHUM and Universite de Montreal, Montreal, Canada.
  • Boz C; KTU Medical Faculty Farabi Hospital, Trabzon, Turkey.
  • Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.
  • McCombe P; University of Queensland, Brisbane, Australia, Royal Brisbane and Women's Hospital.
  • Slee M; Flinders University, Adelaide, Australia.
  • Lechner-Scott J; School of Medicine and Public Health, University Newcastle, Newcastle, Australia; Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, Australia.
  • Turkoglu R; Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
  • Sola P; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
  • Ferraro D; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
  • Granella F; Department of Medicine and Surgery, University of Parma, Parma, Italy; Department of Emergency and General Medicine, Parma University Hospital, Parma, Italy.
  • Shaygannejad V; Isfahan University of Medical Sciences, Isfahan, Iran.
  • Prevost J; CSSS Saint-Jerome, Saint-Jerome, Canada.
  • Skibina O; Monash University, Melbourne, Australia.
  • Solaro C; Department of Neurology, ASL3 Genovese, Genova, Italy; Department of Rehabilitaiton, ML Novarese Hospital Moncrivello.
  • Karabudak R; Hacettepe University, Ankara, Turkey.
  • Wijmeersch BV; Rehabilitation and MS-Centre Overpelt and Hasselt University, Hasselt, Belgium.
  • Csepany T; Department of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Spitaleri D; Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy.
  • Vucic S; Westmead Hospital, Sydney, Australia.
  • Casey R; Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Lyon/Bron, France; Centre des Neurosciences de Lyon, Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, 69003
  • Debouverie M; Centre hospitalier régional universitaire de Nancy, Hôpital central, Service de neurologie, Nancy, France.
  • Edan G; Centre hospitalier universitaire de Rennes, Hôpital Pontchaillou, Service de neurologie, Rennes, France.
Mult Scler Relat Disord ; 53: 103012, 2021 Aug.
Article en En | MEDLINE | ID: mdl-34116480
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Clorhidrato de Fingolimod Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Clorhidrato de Fingolimod Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2021 Tipo del documento: Article